3-Day Opioid Supply at Surgical Discharge Decreases Long-Term Opioid Use
Researchers explored whether a shorter supply of opioids in the postsurgical setting would reduce overall opioid use and decrease conversion to long-term use.
Researchers explored whether a shorter supply of opioids in the postsurgical setting would reduce overall opioid use and decrease conversion to long-term use.
Researchers sought to identify the characteristics likely to precipitate ED visits for pain among patients with cancer.
A study of insurance claims data demonstrated trends in use of opioid and nonopioid medications for managing pain in patients with cancer or chronic noncancer pain.
These strategies follow an overarching recommendation for a stepwise approach that ranges from patient education to pharmaceutical intervention.
A standardized approach is vital for the assessment of neuropathic cancer pain in order to improve treatment results and future clinical/pre-clinical studies.
Opioid products approved by the FDA between 1997 and 2018 relied on short- or intermediate-term studies that did not adequately analyze safety outcomes.
This presentation described an educational initiative that included information about cancer pain and treatments, organizational policy, and opioid equianalgesia.
Cancer survivors have similar rates of prescription opioid misuse versus those without cancer.
Mortality lower despite common opioid prescriptions for cancer-related pain
Investigators at UCSD sought to create a tool to help clinicians predict patients’ risk of persistent opioid use after treatment.